Recomienda este artículo a tus amigos:
Resistance to Targeted Therapies in Lymphomas - Resistance to Targeted Anti-Cancer Therapeutics 2019 edition
Resistance to Targeted Therapies in Lymphomas - Resistance to Targeted Anti-Cancer Therapeutics
Over the past few decades, lymphoma patient outcomes have improved as a result of multidrug chemotherapy and radiation therapy, intensification of treatment, improvement in supportive care, and better imaging and staging systems.
210 pages, 25 Tables, color; 26 Illustrations, color; 1 Illustrations, black and white; XX, 210 p. 2
| Medios de comunicación | Libros Paperback Book (Libro con tapa blanda y lomo encolado) |
| Publicado | 30 de septiembre de 2020 |
| ISBN13 | 9783030244262 |
| Editores | Springer Nature Switzerland AG |
| Páginas | 210 |
| Dimensiones | 150 × 220 × 10 mm · 361 g |
| Lengua | Alemán |
| Editor | Cairo, Mitchell S. |
| Editor | Xavier, Ana C. |